Women with PSVT are often misdiagnosed, referred later than men, and have more symptoms after ablation

References

• Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias–executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003;42:1493–1531.
   PubMed Web of Science ®Google Scholar
• Sohinki D, Obel OA. Current trends in supraventricular tachycardia management. Ochsner J. 2014;14:586–595.
   PubMedGoogle Scholar
• Dagres N, Clague JR, Breithardt G, et al. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol. 2003;42:1103–1107.
   PubMed Web of Science ®Google Scholar
• Wood KA, Stewart AL, Drew BJ, et al. Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia. Heart Lung. 2010;39:12–20.
   PubMed Web of Science ®Google Scholar
• Meissner A, Stifoudi I, Weismüller P, et al. Sustained high quality of life in a 5-year long term follow-up after successful ablation for supra-ventricular tachycardia. Results from a large retrospective patient cohort. Int J Med Sci. 2009;6:28–36.
   PubMed Web of Science ®Google Scholar
• Lane DA, Aguinga L, Blomström-Lundqvist C, et al. Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace. 2015;17:1747–1769.
   PubMed Web of Science ®Google Scholar
• Wood KA, Wiener CL, Kayser-Jones J. Supraventricular tachycardia and the struggle to be believed. Eur J Cardiovasc Nurs. 2007;6:293–302.
   PubMedGoogle Scholar
• Lessmeier TJ, Gamperling D, Johnson-Liddon V, et al. Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder. Arch Intern Med. 1997;157:537–543.
   PubMedGoogle Scholar
• Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24:105–112.
   PubMed Web of Science ®Google Scholar
• Someren MV, Barnard YF, Sandberg JAC. The think aloud method: a practical guide to modelling cognitive processes. London (UK): Academic Press; 1994.
   Google Scholar
• Bubien RS, et al. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94:1585–1591.
   PubMed Web of Science ®Google Scholar
• Sullivan M, Karlsson J, Ware JE, Jr., The Swedish SF-36 Health Survey–I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995;41:1349–1358.
   PubMed Web of Science ®Google Scholar
• Sullivan M, Karlsson J, Ware JE, et al. Swedish manual and interpretation guide. 2nd ed. Gothenburg: Sahlgrenska University Hospital; 2002.
   Google Scholar
• Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19:787–805.
   PubMed Web of Science ®Google Scholar
• Sullivan M, Ahlmen M, Archenholtz B, et al. Measuring health in rheumatic disorders by means of a Swedish version of the sickness impact profile. Results from a population study. Scand J Rheumatol. 1986;15:193–200.
   PubMed Web of Science ®Google Scholar
• Lim KT, Davis MJ, Powell A, et al. Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial. Europace. 2007;9:498–505.
   PubMed Web of Science ®Google Scholar
• Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Prospective randomized study of mode switching in a clinical trial of pacemaker therapy for sinus node dysfunction. J Cardiovasc Electrophysiol. 2004;15:153–160.
   PubMed Web of Science ®Google Scholar
• Braunschweig F, Christel P, Jensen-Urstad M, et al. Paroxysmal regular supraventricular tachycardia: the diagnostic accuracy of the transesophageal ventriculo-atrial interval. Ann Noninvasive Electrocardiol. 2011;16:327–335.
   PubMed Web of Science ®Google Scholar
• Walfridsson U, Walfridsson H, Arestedt K, et al. Impact of radiofrequency ablation on health-related quality of life in patients with paroxysmal supraventricular tachycardia compared with a norm population one year after treatment. Heart Lung. 2011;40:405–411.
   PubMed Web of Science ®Google Scholar
• Farkowski MM, Pytkowski M, Maciag A, et al. Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients’ Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study. Europace. 2014;16:1821–1827.
   PubMed Web of Science ®Google Scholar
• Insulander P, Bastani H, Braunschweig F, et al. Cryoablation of substrates adjacent to the atrioventricular node: acute and long-term safety of 1303 ablation procedures. Europace. 2014;16:271–276.
   PubMed Web of Science ®Google Scholar
• Insulander P, Bastani H, Braunschweig F, et al. Cryoablation of atrioventricular nodal re-entrant tachycardia: 7-year follow-up in 515 patients-confirmed safety but very late recurrences occur. Europace 2017;19:1038–1042.
   PubMed Web of Science ®Google Scholar
• Bastani H, Insulander P, Schwieler J, et al. Safety and efficacy of cryoablation of atrial tachycardia with high risk of ablation-related injuries. Europace. 2009;11:625–629.
   PubMed Web of Science ®Google Scholar